dhvi.duke.edu

GENERAL
META
HTML
LINK ANALYSIS
SERVER
IP

Dhvi.duke.edu recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.

Website Age n/a
Alexa Rank no-data
Country United States
IP Address 152.16.0.235

META INFORMATION

Title

HIV/AIDS Vaccine Durham NC | Duke Human Vaccine Inst**ute

Description

Based in Durham, NC, Duke Human Vaccine Inst**ute (DHVI) is at the forefront of global vaccine research for HIV/AIDS & other diseases.

Keywords

Content Type

utf-8

No	Meta Name	Value
1	viewport	width=device-width, initial-scale=1

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 14.12 %

dhvi.duke.edu has a website text/code ratio of 14.12 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

H11
H210
H34
H41
H50
H60

No	Text
1	Emerging infections research to improve global health

No	Text
1	Search form
2	Programs & ınvestigators
3	Making a difference
4	Opportunity awaits
5	Our mission
6	Our values
7	ın the news
8	Announcements
9	Publications
10	Upcoming events

No	Text
1	Controlling the sars-cov-2 spike glycoprotein conformation
2	3m-052, a synthetic tlr-7/8 agonist, induces durable hıv-1 envelope-specific plasma cells and humoral immunity in nonhuman primates
3	Pandemic preparedness: developing vaccines and ther***utic antibodies for covıd-19
4	Stay up to date

No	Text
1	No events scheduled

Text Styling

STRONG1
B0
EM1
I0
U0
CITE0

STRONG

No	Text
1	Innovation, Collaboration, Excellence

No	Text
1	Innovation, Collaboration, Excellence

LINK ANALYSIS

Total Link Count: 118

Internal Link Count : 105

No	Text	Type
1	News & Events	text
2	Careers	text
3	Give	text
4	-	image
5	About Us	text
6	History	text
7	Leaders***p	text
8	Faculty	text
9	Careers	text
10	Mentoring	text
11	Diversity and Inclusion	text
12	News & Events	text
13	Publications	text
14	Science Culture and Accountability	text
15	Programs and Centers	text
16	Duke Consortia for HIV/AIDS Vaccine Development	text
17	Collaborative Influenza Vaccine Innovation Centers	text
18	HIV Vaccine Research and Development	text
19	Collaboration for AIDS Vaccine Discovery	text
20	Duke Regional Biocontainment Laboratory	text
21	Duke Vaccine Trial Unit	text
22	Mother-Infant Health Programs	text
23	Immunology Virology Quality a***essment Center	text
24	Pandemic Preparedness Programs	text
25	Diseases & Research	text
26	Priority Pathogens	text
27	Shared Resources	text
28	Quant**ative Research Division	text
29	Structural Biology Division	text
30	Good Manufacturing Practice Facility	text
31	-	empty
32	Menu	text
33	About Us	text
34	History	text
35	Leaders***p	text
36	Faculty	text
37	Careers	text
38	Mentoring	text
39	Diversity and Inclusion	text
40	News & Events	text
41	Publications	text
42	Science Culture and Accountability	text
43	Programs and Centers	text
44	Duke Consortia for HIV/AIDS Vaccine Development	text
45	Collaborative Influenza Vaccine Innovation Centers	text
46	HIV Vaccine Research and Development	text
47	Collaboration for AIDS Vaccine Discovery	text
48	Duke Regional Biocontainment Laboratory	text
49	Duke Vaccine Trial Unit	text
50	Mother-Infant Health Programs	text

External Link Count : 13

No	Text	Type
1	Intranet	text
2	-	empty
3	Controlling the SARS-CoV-2 Spike Glycoprotein ConformatioN	text
4	3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates	text
5	Pandemic Preparedness: Developing Vaccines and Ther***utic Antibodies For COVID-19	text
6	-	empty
7	-	empty
8	-	empty
9	Intranet	text
10	Terms & Conditions Policy	text
11	Duke Health	text
12	School of Medicine	text
13	Duke University	text